Search Results

SHOWING THE “LOVE” FOR VISION LOSS RESEARCH

When you first meet the Love boys, Kolton, age 6, and Karson, age 5, you find two active, engaging, and curious young boys who enjoy motor-biking, snowmobiling, playing hockey, and spending time...

FUNDING THE FUTURE: NEW AWARDS ANNOUNCED TO SUPPORT EARLY CAREER CLINICIAN-SCIENTISTS

Fighting Blindness Canada has awarded three new Clinician Scientist Emerging Leader Awards, helping build the pipeline of ophthalmologist researchers. Clinician-scientists can translate laboratory research into the clinic and help bring clinical trials...

2023 INHERITED RETINAL DISEASE RESEARCH UPDATES

September is Inherited Retinal Disease (IRD) Month and we thought it was a great time to share some of the research discoveries that are moving us towards new treatments across different IRDs...

VIEW POINT

Jump to: Understanding the Bionic Eye and Retinal Prostheses| AMD Coffee Connections Ottawa| AMD Coffee Connections North York | View Point Toronto: Speaker Symposium | IRD Spotlight: Syndromic IRDs (Usher and BBS)...

$1.67 MILLION FOR TRANSFORMATIVE RESEARCH INTO RETINAL DEGENERATION

These two awards will fund projects at the forefront of research into glaucoma and inherited retinal diseases. For nearly 50 years, Fighting Blindness Canada has helped move the needle on vision research,...

CANADIANS NOW HAVE ACCESS TO LUXTURNA!

Luxturna is the first gene therapy treatment approved for an inherited retinal disease in Canada. The treatment is for people who have Leber congenital amaurosis (LCA) or retinitis pigmentosa (RP) caused by...